ADMA Biologics Sees FY2026 Sales $530.000M-$560.000M vs $632.367M Est
Benzinga Newsdesk 5 months ago
NewsGuidance
ADMA Biologics (NASDAQ:ADMA) sees FY2026 sales of $530.000 million-$560.000 million vs $632.367 million analyst estimate.
ADMA Biologics (NASDAQ:ADMA) sees FY2026 sales of $530.000 million-$560.000 million vs $632.367 million analyst estimate.